Florida 2025 Regular Session Status: In Committee 1 R cosponsors

SB 1360 — Controlled Substances

Last action — Laid on Table

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Controlled Substances; Excepting from the Schedule I controlled substance xylazine drug products approved by the United States Food and Drug Administration for certain use; creating the offense of trafficking in xylazine, etc.

Bill Text

What changed in the latest version

1324 added · 1385 removed

1324 line(s) added, 1385 removed.

→
Previous
Latest
Florida Senate - 2025 SB 1360 By Senator Leek 7-00152A-25 20251360__ A bill to be entitled An act relating to controlled substances;
Florida Senate - 2025 CS for SB 1360 By the Committee on Criminal Justice;
and Senator Leek 591-02560-25 20251360c1 A bill to be entitled An act relating to controlled substances;
excepting from the Schedule I controlled substance xylazine drug products approved by the United States Food and Drug Administration labeled for and prescribed or dispensed by veterinarians;
excepting from the Schedule I controlled substance xylazine drug products approved by the United States Food and Drug Administration for certain use;
adding xylazine as a Schedule III controlled substance;
excepting from the Schedule III controlled substance xylazine specified drug products approved by the United States Food and Drug Administration;
defining the term “person”;
Paragraph (c) of subsection (1) and paragraph (a) of subsection (3) of section 893.03, Florida Statutes, are amended to read:
Paragraph (c) of subsection (1) of section 893.03, Florida Statutes, is amended to read:
The controlled substances listed or to be listed in Schedules I, II, III, IV, Page 1 of 44 CODING:
The controlled substances listed or to be listed in Schedules I, II, III, IV, and V are included by whatever official, common, usual, chemical, trade name, or class designated.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ and V are included by whatever official, common, usual, chemical, trade name, or class designated.
1308.24, styled “Exempt Chemical Preparations”;
1308.24, styled “Exempt Chemical Page 1 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 Preparations”;
Page 2 of 44 CODING:
5.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 5.
11.
Page 2 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 11.
PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine Page 3 of 44 CODING:
PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine analog of phencyclidine).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ analog of phencyclidine).
Salvia divinorum, except for any drug product approved by the United States Food and Drug Administration which contains Salvia divinorum or its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, if the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.
Salvia divinorum, except for any drug product approved by the United States Food and Drug Administration which contains Salvia divinorum or its isomers, esters, ethers, salts, and Page 3 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 salts of isomers, esters, and ethers, if the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.
Xylazine, except for any drug product approved by the United States Food and Drug Administration which contains xylazine or a compounded form of xylazine labeled for veterinary use and prescribed or dispensed by a veterinarian licensed under chapter 474.
Xylazine, except for a xylazine animal drug product approved by the United States Food and Drug Administration, the use of which conforms to the approved application or is authorized under 21 U.S.C.
s.
360b(a)(4).
The manufacture, importation, distribution, prescribing, or sale of xylazine for human use is not subject to this exception.
Page 4 of 44 CODING:
46.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 46.
49.
Page 4 of 42 CODING:
Show all 325 changed rows (285 more)
Previous
Latest
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 49.
Page 5 of 44 CODING:
71.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 71.
76.
Page 5 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 76.
Page 6 of 44 CODING:
98.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 98.
MDPBP (3,4-Methylenedioxy-alpha- pyrrolidinobutyrophenone).
MDPBP (3,4-Methylenedioxy-alpha- Page 6 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 pyrrolidinobutyrophenone).
JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan- Page 7 of 44 CODING:
JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan- 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
126.
Page 7 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 126.
RCS-8 (1-(2-Cyclohexylethyl)-3-(2- Page 8 of 44 CODING:
RCS-8 (1-(2-Cyclohexylethyl)-3-(2- methoxyphenylacetyl)indole).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ methoxyphenylacetyl)indole).
WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4- morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone).
WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4- Page 8 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone).
Page 9 of 44 CODING:
158.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 158.
161.
Page 9 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 161.
25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2- Page 10 of 44 CODING:
25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2- methoxybenzyl)]phenethylamine).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ methoxybenzyl)]phenethylamine).
178.
Page 10 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 178.
Page 11 of 44 CODING:
190.
Synthetic Cannabinoids.—Unless specifically excepted or unless listed in another schedule or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation that contains any quantity of a synthetic Page 11 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 190.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 cannabinoid found to be in any of the following chemical class descriptions, or homologues, nitrogen-heterocyclic analogs, isomers (including optical, positional, or geometric), esters, ethers, salts, and salts of homologues, nitrogen-heterocyclic analogs, isomers, esters, or ethers, whenever the existence of such homologues, nitrogen-heterocyclic analogs, isomers, esters, ethers, salts, and salts of isomers, esters, or ethers is possible within the specific chemical class or designation.
Synthetic Cannabinoids.—Unless specifically excepted or unless listed in another schedule or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation that contains any quantity of a synthetic cannabinoid found to be in any of the following chemical class descriptions, or homologues, nitrogen-heterocyclic analogs, isomers (including optical, positional, or geometric), esters, ethers, salts, and salts of homologues, nitrogen-heterocyclic analogs, isomers, esters, or ethers, whenever the existence of such homologues, nitrogen-heterocyclic analogs, isomers, esters, ethers, salts, and salts of isomers, esters, or ethers is possible within the specific chemical class or designation.
Tetrahydrocannabinols.—Any tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, the synthetic equivalents of the substances contained in the plant or in the resinous extracts of the genus Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity, including, but not limited to, Delta 9 tetrahydrocannabinols and their optical isomers, Delta 8 tetrahydrocannabinols and their optical Page 12 of 44 CODING:
Tetrahydrocannabinols.—Any tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, the synthetic equivalents of the substances contained in the plant or in the resinous extracts of the genus Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity, including, but not limited to, Delta 9 tetrahydrocannabinols and their optical isomers, Delta 8 tetrahydrocannabinols and their optical isomers, Delta 6a,10a tetrahydrocannabinols and their optical isomers, or any compound containing a tetrahydrobenzo[c]chromene structure with substitution at either or both the 3-position or 9-position, with or without substitution at the 1-position with hydroxyl or alkoxy groups, including, but not limited to:
Page 12 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ isomers, Delta 6a,10a tetrahydrocannabinols and their optical isomers, or any compound containing a tetrahydrobenzo[c]chromene structure with substitution at either or both the 3-position or 9-position, with or without substitution at the 1-position with hydroxyl or alkoxy groups, including, but not limited to:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (I) Tetrahydrocannabinol.
(I) Tetrahydrocannabinol.
Naphthoylindoles, Naphthoylindazoles, Naphthoylcarbazoles, Naphthylmethylindoles, Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any compound containing a naphthoylindole, naphthoylindazole, Page 13 of 44 CODING:
Naphthoylindoles, Naphthoylindazoles, Naphthoylcarbazoles, Naphthylmethylindoles, Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any compound containing a naphthoylindole, naphthoylindazole, naphthoylcarbazole, naphthylmethylindole, naphthylmethylindazole, or naphthylmethylcarbazole structure, with or without substitution on the indole, indazole, or carbazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:
Page 13 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ naphthoylcarbazole, naphthylmethylindole, naphthylmethylindazole, or naphthylmethylcarbazole structure, with or without substitution on the indole, indazole, or carbazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
Page 14 of 44 CODING:
(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1- naphthylmethyl]indole).
(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1- naphthoyl)indole).
(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1- Page 14 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1- naphthylmethyl]indole).
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 naphthoyl)indole).
(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1- naphthoyl)indole).
(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1- naphthoyl)indole).
(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1- Page 15 of 44 CODING:
(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1- naphthoyl)indole).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ naphthoyl)indole).
Naphthoylpyrroles.—Any compound containing a naphthoylpyrrole structure, with or without substitution on the pyrrole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:
Naphthoylpyrroles.—Any compound containing a Page 15 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 naphthoylpyrrole structure, with or without substitution on the pyrrole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:
Page 16 of 44 CODING:
e.
Phenylacetylindoles and Phenylacetylindazoles.—Any compound containing a phenylacetylindole or phenylacetylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring to any extent, including, but not limited to:
Page 16 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ e.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
Phenylacetylindoles and Phenylacetylindazoles.—Any compound containing a phenylacetylindole or phenylacetylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring to any extent, including, but not limited to:
(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
Benzoylindoles and Benzoylindazoles.—Any compound containing a benzoylindole or benzoylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring to any Page 17 of 44 CODING:
Benzoylindoles and Benzoylindazoles.—Any compound containing a benzoylindole or benzoylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring to any extent, including, but not limited to:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ extent, including, but not limited to:
(IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4- methoxybenzoyl)indole).
Page 17 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4- methoxybenzoyl)indole).
Page 18 of 44 CODING:
(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3- tetramethylcyclopropanoyl)indole).
(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3- tetramethylcyclopropanoyl)indole).
(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3- Page 18 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3- tetramethylcyclopropanoyl)indole).
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 tetramethylcyclopropanoyl)indole).
(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3- tetramethylcyclopropanoyl)indole).
(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3- tetramethylcyclopropanoyl)indole).
(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1- Page 19 of 44 CODING:
(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1- adamantoyl)indole).
j.
Quinolinylindolecarboxylates, Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, and Quinolinylindazolecarboxamides.—Any compound containing a quinolinylindole carboxylate, quinolinylindazole carboxylate, Page 19 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ adamantoyl)indole).
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 isoquinolinylindole carboxylate, isoquinolinylindazole carboxylate, quinolinylindole carboxamide, quinolinylindazole carboxamide, isoquinolinylindole carboxamide, or isoquinolinylindazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the quinoline or isoquinoline ring to any extent, including, but not limited to:
j.
Quinolinylindolecarboxylates, Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, and Quinolinylindazolecarboxamides.—Any compound containing a quinolinylindole carboxylate, quinolinylindazole carboxylate, isoquinolinylindole carboxylate, isoquinolinylindazole carboxylate, quinolinylindole carboxamide, quinolinylindazole carboxamide, isoquinolinylindole carboxamide, or isoquinolinylindazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the quinoline or isoquinoline ring to any extent, including, but not limited to:
Naphthylindolecarboxylates and Naphthylindazolecarboxylates.—Any compound containing a Page 20 of 44 CODING:
Naphthylindolecarboxylates and Naphthylindazolecarboxylates.—Any compound containing a naphthylindole carboxylate or naphthylindazole carboxylate structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:
(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3- Page 20 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ naphthylindole carboxylate or naphthylindazole carboxylate structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 carboxylate).
(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3- carboxylate).
Page 21 of 44 CODING:
m.
Alkylcarbonyl indole carboxamides, Alkylcarbonyl indazole carboxamides, Alkylcarbonyl indole carboxylates, and Alkylcarbonyl indazole carboxylates.—Any compound containing an alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3- Page 21 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ m.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an indole carboxamide, indazole carboxamide, indole carboxylate, or indazole carboxylate, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the alkylcarbonyl group to any extent, including, but not limited to:
Alkylcarbonyl indole carboxamides, Alkylcarbonyl indazole carboxamides, Alkylcarbonyl indole carboxylates, and Alkylcarbonyl indazole carboxylates.—Any compound containing an alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3- phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an indole carboxamide, indazole carboxamide, indole carboxylate, or indazole carboxylate, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the alkylcarbonyl group to any extent, including, but not limited to:
Page 22 of 44 CODING:
(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)indazole-3-carboxamide).
(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)indazole-3-carboxamide).
(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2- Page 22 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)indazole-3-carboxamide).
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)indazole-3-carboxamide).
(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2- yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
Cumylindolecarboxamides and Cumylindazolecarboxamides.— Page 23 of 44 CODING:
Cumylindolecarboxamides and Cumylindazolecarboxamides.— Any compound containing a N-(2-phenylpropan-2-yl) indole carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring of the cumyl group to any extent, including, but not Page 23 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ Any compound containing a N-(2-phenylpropan-2-yl) indole carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring of the cumyl group to any extent, including, but not limited to:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 limited to:
Substituted Cathinones.—Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, Page 24 of 44 CODING:
Substituted Cathinones.—Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations:
a.
Any compound containing a 2-amino-1-phenyl-1-propanone Page 24 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 structure;
a.
Any compound containing a 2-amino-1-phenyl-1-propanone structure;
Page 25 of 44 CODING:
(E) MDPV (3,4-Methylenedioxypyrovalerone).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (E) MDPV (3,4-Methylenedioxypyrovalerone).
(J) Butylone (3,4-Methylenedioxy-alpha- methylaminobutyrophenone).
Page 25 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (J) Butylone (3,4-Methylenedioxy-alpha- methylaminobutyrophenone).
Page 26 of 44 CODING:
(BB) F-MABP (Fluoromethylaminobutyrophenone).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (BB) F-MABP (Fluoromethylaminobutyrophenone).
(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
Page 26 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
Substituted Phenethylamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations, any compound containing a phenethylamine structure, without a beta-keto group, and without a benzyl group Page 27 of 44 CODING:
Substituted Phenethylamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations, any compound containing a phenethylamine structure, without a beta-keto group, and without a benzyl group attached to the amine group, whether or not the compound is further modified with or without substitution on the phenyl ring to any extent with alkyl, alkylthio, nitro, alkoxy, thio, halide, fused alkylenedioxy, fused furan, fused benzofuran, fused dihydrofuran, or fused tetrahydropyran substituents, Page 27 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ attached to the amine group, whether or not the compound is further modified with or without substitution on the phenyl ring to any extent with alkyl, alkylthio, nitro, alkoxy, thio, halide, fused alkylenedioxy, fused furan, fused benzofuran, fused dihydrofuran, or fused tetrahydropyran substituents, whether or not further substituted on a ring to any extent, with or without substitution at the alpha or beta position by any alkyl substituent, with or without substitution at the nitrogen atom, and with or without inclusion of the 2-amino nitrogen atom in a cyclic structure, including, but not limited to:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 whether or not further substituted on a ring to any extent, with or without substitution at the alpha or beta position by any alkyl substituent, with or without substitution at the nitrogen atom, and with or without inclusion of the 2-amino nitrogen atom in a cyclic structure, including, but not limited to:
Page 28 of 44 CODING:
s.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ s.
x.
Page 28 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 x.
5-MAPDB (5-(2-Methylaminopropyl)-2,3- dihydrobenzofuran), Page 29 of 44 CODING:
5-MAPDB (5-(2-Methylaminopropyl)-2,3- dihydrobenzofuran), which does not include phenethylamine, mescaline as described in subparagraph 20., substituted cathinones as described in subparagraph 191., N-Benzyl phenethylamine compounds as described in subparagraph 193., or methamphetamine as described in subparagraph (2)(c)5.
Page 29 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ which does not include phenethylamine, mescaline as described in subparagraph 20., substituted cathinones as described in subparagraph 191., N-Benzyl phenethylamine compounds as described in subparagraph 193., or methamphetamine as described in subparagraph (2)(c)5.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 193.
193.
25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3- Page 30 of 44 CODING:
25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3- methylenedioxybenzyl)]phenethylamine).
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ methylenedioxybenzyl)]phenethylamine).
g.
Page 30 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 g.
Page 31 of 44 CODING:
s.
25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2- methoxybenzyl)]phenethylamine), which does not include substituted cathinones as described in subparagraph 191.
Page 31 of 42 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ s.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 194.
25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2- methoxybenzyl)]phenethylamine), which does not include substituted cathinones as described in subparagraph 191.
194.
Page 32 of 44 CODING:
m.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ m.
r.
Page 32 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 r.
Substituted Phenylcyclohexylamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation containing a phenylcyclohexylamine structure, with or without any substitution on the phenyl ring, any substitution on the cyclohexyl ring, any replacement of the phenyl ring with a thiophenyl or benzothiophenyl ring, with or without substitution on the amine with alkyl, dialkyl, or alkoxy substituents, inclusion of the nitrogen in a cyclic structure, Page 33 of 44 CODING:
Substituted Phenylcyclohexylamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation containing a phenylcyclohexylamine structure, with or without any substitution on the phenyl ring, any substitution on the cyclohexyl ring, any replacement of the phenyl ring with a thiophenyl or benzothiophenyl ring, with or without substitution on the amine with alkyl, dialkyl, or alkoxy substituents, inclusion of the nitrogen in a cyclic structure, or any combination of the above, including, but not limited to:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ or any combination of the above, including, but not limited to:
c.
Page 33 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 c.
Page 34 of 44 CODING:
199.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 199.
(3) SCHEDULE III.—A substance in Schedule III has a potential for abuse less than the substances contained in Schedules I and II and has a currently accepted medical use in treatment in the United States, and abuse of the substance may lead to moderate or low physical dependence or high psychological dependence or, in the case of anabolic steroids, may lead to physical damage.
The following substances are controlled in Schedule III:
(a) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant or stimulant effect on the nervous system:
1.
Any substance which contains any quantity of a derivative of barbituric acid, including thiobarbituric acid, or any salt of a derivative of barbituric acid or thiobarbituric acid, including, but not limited to, butabarbital and butalbital.
2.
Benzphetamine.
3.
Buprenorphine.
4.
Chlorhexadol.
5.
Chlorphentermine.
6.
Clortermine.
7.
Embutramide.
8.
Lysergic acid.
Page 35 of 44 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ 9.
Lysergic acid amide.
10.
Methyprylon.
11.
Perampanel.
12.
Phendimetrazine.
13.
Sulfondiethylmethane.
14.
Sulfonethylmethane.
15.
Sulfonmethane.
16.
Tiletamine and zolazepam or any salt thereof.
17.
Xylazine, except for any drug product approved by the United States Food and Drug Administration which contains xylazine or a compounded form of xylazine labeled for veterinary use, which product is prescribed or dispensed by a veterinarian licensed under chapter 474 or labeled and dispensed by a veterinarian licensed under chapter 474 or a pharmacy registered in this state pursuant to a prescription from a veterinarian licensed under chapter 474 who possesses xylazine for:
a.
An animal owned by or under a veterinarian’s care.
As used in this sub-subparagraph, the term “veterinarian” includes a government agency or business where animals are located, and an employee or agent of an agency or business acting within the scope of their employment or agency.
b.
Use in governmental animal-control programs authorized under applicable federal, state, local, or tribal law.
c.
Use in wildlife programs authorized under applicable federal, state, local, or tribal law.
Paragraph (i) of subsection (1) of section 893.13, Florida Statutes, is amended to read:
Paragraph (i) of subsection (1) of section Page 34 of 42 CODING:
893.13 Prohibited acts;
penalties.— (1) Page 36 of 44 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (i) Except as authorized by this chapter, a person commits a felony of the first degree, punishable as provided in s.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 893.13, Florida Statutes, is amended to read:
893.13 Prohibited acts;
penalties.— (1) (i) Except as authorized by this chapter, a person commits a felony of the first degree, punishable as provided in s.
Resembles the trade dress of a branded food product, consumer food product, or logo food product;
Resembles the trade dress of a branded food product, Page 35 of 42 CODING:
b.
Incorporates an actual or fake registered copyright, service mark, or trademark;
Page 37 of 44 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ c.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 consumer food product, or logo food product;
b.
Incorporates an actual or fake registered copyright, service mark, or trademark;
c.
Is 14 grams or more, but less than 28 grams, such person shall be sentenced to a mandatory minimum term of imprisonment of 15 years and shall be ordered to pay a fine of $100,000.
Is 14 grams or more, but less than 28 grams, such person shall be sentenced to a mandatory minimum term of imprisonment Page 36 of 42 CODING:
c.
Is 28 grams or more, but less than 30 kilograms, such person shall be sentenced to a mandatory minimum term of Page 38 of 44 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ imprisonment of 25 years and shall be ordered to pay a fine of $500,000.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 of 15 years and shall be ordered to pay a fine of $100,000.
c.
Is 28 grams or more, but less than 30 kilograms, such person shall be sentenced to a mandatory minimum term of imprisonment of 25 years and shall be ordered to pay a fine of $500,000.
3.
Page 37 of 42 CODING:
A person who knowingly sells, purchases, manufactures, delivers, or brings into this state, or who is knowingly in actual or constructive possession of, 7 grams or more of Page 39 of 44 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ oxycodone, as described in s.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 3.
A person who knowingly sells, purchases, manufactures, delivers, or brings into this state, or who is knowingly in actual or constructive possession of, 7 grams or more of oxycodone, as described in s.
(IV) Sufentanil, as described in s.
Page 38 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 (IV) Sufentanil, as described in s.
Page 40 of 44 CODING:
(VI) A controlled substance analog, as described in s.
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ (VI) A controlled substance analog, as described in s.
shall be sentenced to a mandatory minimum term of not less than 25 years and not exceeding life imprisonment, and shall be ordered to pay a fine of $1 million if the substance or mixture listed in sub-subparagraph a.
shall be sentenced to a mandatory minimum term of not less than 25 years and not exceeding life imprisonment, Page 39 of 42 CODING:
is in a form that resembles, or is mixed, granulated, absorbed, spray-dried, Page 41 of 44 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ or aerosolized as or onto, coated on, in whole or in part, or solubilized with or into, a product, when such product or its packaging further has at least one of the following attributes:
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 and shall be ordered to pay a fine of $1 million if the substance or mixture listed in sub-subparagraph a.
is in a form that resembles, or is mixed, granulated, absorbed, spray-dried, or aerosolized as or onto, coated on, in whole or in part, or solubilized with or into, a product, when such product or its packaging further has at least one of the following attributes:
a.
Page 40 of 42 CODING:
The person intentionally killed an individual or counseled, commanded, induced, procured, or caused the intentional killing of an individual and such killing was the Page 42 of 44 CODING:
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ result;
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 a.
The person intentionally killed an individual or counseled, commanded, induced, procured, or caused the intentional killing of an individual and such killing was the result;
893.03(1)(c)37., or any salt thereof, or 4 grams or more of any mixture containing any such substance, commits a felony of the first degree, which felony shall be known as “trafficking in xylazine,” punishable as provided in s.
893.03(1)(c)37., or any salt thereof, or 4 grams or more of any mixture containing any such Page 41 of 42 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 CS for SB 1360 591-02560-25 20251360c1 substance, commits a felony of the first degree, which felony shall be known as “trafficking in xylazine,” punishable as provided in s.
If the Page 43 of 44 CODING:
If the quantity involved:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2025 SB 1360 7-00152A-25 20251360__ quantity involved:
Page 44 of 44 CODING:
Page 42 of 42 CODING:
⬇ Download PDF
View plain text versions (2)

Action History

  1. Laid on Table

  2. Substituted CS/HB 57 (Died in returning Messages)

  3. Read 2nd time

  4. Placed on Special Order Calendar, 04/30/25

  5. Placed on Calendar, on 2nd reading

  6. Favorable by- Fiscal Policy; YEAS 15 NAYS 3

  7. On Committee agenda-- Fiscal Policy, 04/22/25, 11:00 am, 412 Knott Building

  8. Now in Fiscal Policy

  9. Favorable by Appropriations Committee on Criminal and Civil Justice; YEAS 8 NAYS 0

  10. On Committee agenda-- Appropriations Committee on Criminal and Civil Justice, 04/15/25, 12:30 pm, 37 Senate Building

  11. CS by Criminal Justice read 1st time

  12. Now in Appropriations Committee on Criminal and Civil Justice

  13. Pending reference review under Rule 4.7(2) - (Committee Substitute)

  14. CS by Criminal Justice; YEAS 8 NAYS 1

  15. On Committee agenda-- Criminal Justice, 03/18/25, 3:30 pm, 37 Senate Building

  16. Introduced

  17. Referred to Criminal Justice; Appropriations Committee on Criminal and Civil Justice; Fiscal Policy

  18. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 0 co-sponsors · 162 not signed on · 4 voted No

Sponsors (2)

Co-sponsors (0)

None.

Not signed on (162)

162 members have not signed on to this bill.

Show all 162 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Favorable

Passed 15 Yea · 3 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 2300
Republican 12001
Unaffiliated 1000
Total 15301
% of votes cast 79%16%0%5%
How each member voted (19)
Member Party Vote
Ingoglia — Yea
Arrington, Kristen Aston Democrat Yea
Bernard, Mack Democrat Yea
Davis, Tracie Democrat Nay
Jones, Shevrin D. "Shev" Democrat Nay
Osgood, Rosalind Democrat Nay
Boyd, Jim Republican Yea
Bradley, Jennifer Republican Yea
Burton, Colleen Republican Yea
Calatayud, Alexis Republican Yea
Gaetz, Don Republican Yea
Gruters, Joe Republican Yea
Leek, Thomas J. "Tom" Republican Yea
Passidomo, Kathleen Republican Yea
Rodriguez, Ana Maria Republican Yea
Simon, Corey Republican Yea
Truenow, Keith L. Republican Yea
Vacant Republican Yea
Yarborough, Clay Republican Not Voting

Official roll call →

Favorable

Passed 8 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 1000
Democrat 3000
Republican 4001
Total 8001
% of votes cast 89%0%0%11%
How each member voted (9)
Member Party Vote
Ingoglia — Yea
Osgood, Rosalind Democrat Yea
Polsky, Tina Scott Democrat Yea
Rouson, Darryl Ervin Democrat Yea
Garcia, Ileana Republican Yea
Martin, Jonathan Republican Yea
Simon, Corey Republican Yea
Wright, Tom A. Republican Yea
Yarborough, Clay Republican Not Voting

Official roll call →

Favorable with Committee Substitute

Passed 8 Yea · 1 Nay
Party YeaNayPresentNot Voting
Democrat 1100
Republican 6000
No Party Affiliation 1000
Total 8100
% of votes cast 89%11%0%0%
How each member voted (9)
Member Party Vote
Bernard, Mack Democrat Yea
Smith, Carlos Guillermo Democrat Nay
Pizzo, Jason W. B. No Party Affiliation Yea
Bradley, Jennifer Republican Yea
Garcia, Ileana Republican Yea
Gruters, Joe Republican Yea
Martin, Jonathan Republican Yea
Simon, Corey Republican Yea
Yarborough, Clay Republican Yea

Official roll call →

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 1360 do?
Controlled Substances; Excepting from the Schedule I controlled substance xylazine drug products approved by the United States Food and Drug Administration for certain use; creating the offense of trafficking in xylazine, etc.
Who sponsors SB 1360?
SB 1360 is sponsored by Leek, Thomas J. "Tom" (Republican) and Criminal Justice.
What is the current status of SB 1360?
This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 1360?
Track SB 1360 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1360

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1360

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →